Title  | Date  | Price |
|---|
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
| Apr 2008 |
£1,715 |
MarketWatch: Biotechnology
| Apr 2008 |
£110 |
Biogenerics, The World Market
Biosimilars and Follow-On Biologics at a Crossroads
| Apr 2008 |
£1,765 |
Somaxon Pharmaceuticals Inc
Premium Company Profile
| Mar 2008 |
£265 |
Threshold Pharmaceuticals Inc
Premium Company Profile
| Mar 2008 |
£265 |
The Fastest Growing Biotechnology Companies
Growth Strategies, Comparative Analyses and Company Profiles
| Mar 2008 |
£1,995 |
Global Biotechnology
| Feb 2008 |
£380 |
Biotechnology in the US
| Jan 2008 |
£330 |
QLT Inc: Premium Company Profile
| Jan 2008 |
£265 |
Martek Biosciences Corp: Premium Company Profile
| Jan 2008 |
£265 |
ADME/Tox Technologies
| Jan 2008 |
£1,475 |
Global Dialysis Market: Hemodialysis Continues to be the Preferred Treatment
| Jan 2008 |
£430 |
hERG Screening
| Jan 2008 |
£1,490 |
RNAi
| Jan 2008 |
£2,270 |
DNA Sequencing
| Jan 2008 |
£2,270 |
Apoptosis
| Jan 2008 |
£1,465 |
Antibiotics and Drug Resistance 2008
Drug Innovation and the Strategy to Combat - Antibiotic Resistance Mechanisms
| Jan 2008 |
£1,499 |
Biological Implants
| Jan 2008 |
£1,915 |
Angiogenesis Modulators
| Jan 2008 |
£1,410 |
Innovations in Bioinformatics
Emerging Tools for Drug Discovery and Development
| Jan 2008 |
£1,995 |
ArQule Inc: Premium Company Profile
| Jan 2008 |
£265 |
Gpc Biotech Ag: Premium Company Profile
| Jan 2008 |
£265 |
Warner Chilcott Ltd: Premium Company Profile
| Jan 2008 |
£265 |
Epix Pharmaceuticals Inc: Premium Company Profile
| Jan 2008 |
£265 |
Neurogen Corporation: Premium Company Profile
| Jan 2008 |
£265 |
Gtc Biotherapeutics Inc: Premium Company Profile
| Jan 2008 |
£265 |
Indian Biopharmaceuticals
| Jan 2008 |
£600 |
Indian Biotechnology
| Jan 2008 |
£600 |
High Throughput Screening
| Jan 2008 |
£1,550 |
Biomarkers
| Jan 2008 |
£1,670 |
Metabolomics
| Jan 2008 |
£1,390 |
Stem Cell Research
| Jan 2008 |
£2,145 |
Catholic Health Initiatives - SWOT Analysis
| Dec 2007 |
£63 |
Solvay S.A.
PharmaVitae Profile
| Dec 2007 |
£2,995 |
Nektar Therapeutics: Premium Company Profile
| Dec 2007 |
£265 |
Theravance Inc: Premium Company Profile
| Dec 2007 |
£265 |
Renovis: Premium Company Profile
| Dec 2007 |
£265 |
Axcan Pharma Inc: Premium Company Profile
| Dec 2007 |
£265 |
Pharmacopeia Inc: Premium Company Profile
| Dec 2007 |
£265 |
CombinatoRx Incorporated: Premium Company Profile
| Dec 2007 |
£265 |
Pozen Inc: Premium Company Profile
| Dec 2007 |
£265 |
Vical Incorporated: Premium Company Profile
| Dec 2007 |
£265 |
Omrix Biopharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
Momenta Pharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
Millennium Pharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
Sciele Pharma Inc: Premium Company Profile
| Dec 2007 |
£265 |
InterMune Inc: Premium Company Profile
| Dec 2007 |
£265 |
Labopharm Inc: Premium Company Profile
| Dec 2007 |
£265 |
XenoPort Inc: Premium Company Profile
| Dec 2007 |
£265 |
SuperGen Inc: Premium Company Profile
| Dec 2007 |
£265 |
Xoma Limited: Premium Company Profile
| Dec 2007 |
£265 |
Regeneron Pharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
Salix Pharmaceuticals Ltd: Premium Company Profile
| Dec 2007 |
£265 |
Medicis Pharmaceutical Corporation: Premium Company Profile
| Dec 2007 |
£265 |
Trimeris, Inc. : Premium Company Profile
| Dec 2007 |
£265 |
Sgx Pharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
Genta Incorporated: Premium Company Profile
| Dec 2007 |
£265 |
Indevus Pharmaceuticals: Premium Company Profile
| Dec 2007 |
£265 |
Critical Therapeutics Inc: Premium Company Profile
| Dec 2007 |
£265 |
Tercica Inc: Premium Company Profile
| Dec 2007 |
£265 |
Array BioPharma Inc. : Premium Company Profile
| Dec 2007 |
£265 |
Alkermes Inc: Premium Company Profile
| Dec 2007 |
£265 |
NitroMed, Inc : Premium Company Profile
| Dec 2007 |
£265 |
Isis Pharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
Infinity Pharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
BioCryst Pharmaceuticals Inc: Premium Company Profile
| Dec 2007 |
£265 |
Biotechnology in Australia
IBISWorld Industry Report
| Dec 2007 |
£360 |
China Biopharmaceutical Industry Report, 2007-2008
| Dec 2007 |
£1,010 |
Stryker Corporation - SWOT Analysis
| Dec 2007 |
£63 |
The Global Biometrics Market
| Dec 2007 |
£2,445 |
Immunogenicity to Biologics
Implications Of Reactions Against Biotech Drugs
| Nov 2007 |
£1,450 |
Premium Company Profile: BioMarin Pharmaceutical Inc.
| Nov 2007 |
£265 |
Premium Company Profile: Invitrogen Corporation
| Nov 2007 |
£265 |
Premium Company Profile Aspreva Pharmaceuticals Corporation
| Nov 2007 |
£265 |
New Technologies and Demographics Driving Hip Implant Market
| Nov 2007 |
£405 |
Expanding Opportunities in Contract Research and Contract Manufacture Of Biotherapeutics/Biologics
| Nov 2007 |
£500 |
Biomarkers
The Expanding Global Market
| Nov 2007 |
£2,445 |
Global Cardiac Rhythm Management Market
ICDs and Emerging Markets to Drive Growth
| Nov 2007 |
£455 |
Biosimilars: a market coming of age?
| Oct 2007 |
£995 |
Biotechnology: Global Industry Guide
| Oct 2007 |
£525 |
Biosimilars Series
Strategic Issues - Potential Remains Uncertain
| Oct 2007 |
£2,000 |
Monoclonal Antibodies Report Part II
Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff
| Sep 2007 |
£3,800 |
Global Protein Therapeutics Market Analysis
| Sep 2007 |
£910 |
Global Bioinformatics Market Outlook
| Sep 2007 |
£605 |
Demographic Trends Driving Medical Imaging Market
| Sep 2007 |
£405 |
Biotechnology in Germany
| Aug 2007 |
£125 |
Global Biotechnology
| Aug 2007 |
£125 |
Biotechnology in Asia-Pacific
| Aug 2007 |
£125 |
Biotechnology in Belgium
| Aug 2007 |
£125 |
Biotechnology in Canada
| Aug 2007 |
£125 |
Biotechnology in China
| Aug 2007 |
£125 |
Biotechnology in Europe
| Aug 2007 |
£125 |
Biotechnology in France
| Aug 2007 |
£125 |
Biotechnology in Italy
| Aug 2007 |
£125 |
Biotechnology in Japan
| Aug 2007 |
£125 |
Biotechnology in Spain
| Aug 2007 |
£125 |
Biotechnology in the Netherlands
| Aug 2007 |
£125 |
Biotechnology in the United Kingdom
| Aug 2007 |
£125 |
Biotechnology in the United States
| Aug 2007 |
£125 |
Personalized Medicine
| Aug 2007 |
£1,010 |
previous
